The patented stem cell science behind CALECIM®

The story of CALECIM^® Cosmeceuticals traces back to science and a specific discovery that is so revolutionary to stem cell science, it’s been patented in 41 territories globally. Given their potential for medical therapy, it’s no wonder that stem cells are being researched intensively around the world. CellResearch Corporation, the parent company of ground-breaking skincare line CALECIM^® Professional, is one of those leading global research in stem cell science.

Featured Products

Professional Serum 5ml

Contains the highest concentration of PTT-6^® to reduce fine lines and wrinkles

Multi-Action Cream

Helps boost collagen and elastin production

Professional Pigment Solution

Superior treatment for uneven skin tone and hyperpigmentation

Recovery Night Complex

Use overnight to hydrate, brighten, and repair skin with stem cell proteins

Restorative Hydration Cream

Deeply hydrates and replenishes dry, dull skin

Advanced Hair System

The 6-week hair loss treatment with clinically validated results

About CellResearch Corporation: An expert on stem cell skin repair

Biotech company CellResearchCorp. was founded by three partners with an interest in cell biology. Based in Singapore, CellResearch Corp. focused its research on the umbilical cord lining. This cord lining is one of the richest known sources of neonatal cells, which hold far more powerful properties than adult stem cells. In 2004, CellResearchCorp.’s scientists discovered a way to isolate epithelial and mesenchymal stem cells from the umbilical cord lining membrane. The company immediately put this discovery up for intellectual property protection.

Our patented technology: the creation of a unique stem cell skin and hair care product

CellResearchCorp. was granted patents that cover the concept of obtaining stem cells from mammalian umbilical cord lining and specifically the techniques of isolating and cultivating epithelial and mesenchymal stem cells. The company also secured patents that encompass all applications using umbilical cord lining stem cells, including therapeutic applications.

With these patents in hand, no other manufacturers can use CellResearchCorp.’s stem cell technology for any skin and hair care or therapeutic applications. As a result, the products and therapies developed by CellResearchCorp. stand alone, both in the medical arena and in the field of skin care.

Patent Scope and Coverage

CellResearchCorp. holds patents for umbilical cord lining stem cell technology and the products derived therefrom in 41 territories across the world, including The United States, as well as in Europe, China, The United Kingdom, Singapore, Malaysia, Japan, Taiwan, and South Korea.

Applying our knowledge to skincare: Using stem cell derived PTT-6^®

Right from the beginning, CellResearchCorp. has directed its patented stem cell knowledge toward the treatment of skin, specifically wounds and other related diseases, partnering with hospitals, universities, and doctors along the way. Now, the founders of CellResearch Corp. are channeling two decades of stem cell expertise into advanced cosmetic skin and hair care under the CALECIM^®Professional line—a true first for the beauty industry.

All CALECIM^®Professional products contain PTT-6^® , a protein-rich formula of nutrients extracted from cord lining stem cells. Carefully created in CellResearchCorp.’s Singapore labs, this formula allows the renewal properties from cord lining stem cells to rejuvenate the skin. The powerful active ingredients, that include growth factors and exosomes in PTT-6^® stimulate the skin to act and look younger, restoring its natural texture, firmness, and elasticity.